NIHON CHOUZAI Co.,Ltd.

3341

JP3729200000

Drug Retailers

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-19 am EDT			5-day change	1st Jan Change
1,507 ^JPY	-2.40%		-2.08%	+7.72%

Mar. 25	Nihon Chouzai to Meet Tradable Share Ratio Requirement by June	MT
2023	NIHON CHOUZAI Co.,Ltd Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 6, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	CI

NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

October 31, 2022 at 02:00 am EDT

NIHON CHOUZAI Co.,Ltd. provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of JPY 321,400 million, operating profit of JPY 8,500 million, profit attributable to owners of parent JPY 4,400 million and basic earnings per share of JPY 146.73.

Latest news about NIHON CHOUZAI Co.,Ltd.

Nihon Chouzai to Meet Tradable Share Ratio Requirement by June	Mar. 25	MT
NIHON CHOUZAI Co.,Ltd Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 6, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-10-31	CI
NIHON CHOUZAI Co.,Ltd. Provides Earnings Guidance for the Year Ending March 31, 2024	23-10-31	CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal 2024 and the Full Year Ending March 31, 2024	23-07-31	CI
NIHON CHOUZAI Co.,Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and the Full Year Ending March 31, 2024	23-07-31	CI
NIHON CHOUZAI Co.,Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 26, 2023; Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending March 31, 2024	23-04-28	CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal 2024 and the Full Year Ending March 31, 2024	23-04-28	CI
NIHON CHOUZAI Co.,Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023	23-01-31	CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023	23-01-31	CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023	22-10-31	CI
Nihon Chouzai Co.,Ltd. Announces Dividend for the Second Quarter Ended of the Fiscal Year 2023, Payable on December 6, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023	22-10-31	CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Forecast for the First Half and Full Year of Fiscal Year Ending March 31, 2023	22-07-29	CI
NIHON CHOUZAI Co.,Ltd. Provides Dividend Guidance for the Second Quarter and Year-End of Fiscal Year Ending March 31, 2023	22-07-29	CI
Nihon Chouzai Co.,Ltd. Announces Dividend for the Year Ended March 31, 2022, Payable on June 24, 2022; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2023	22-04-28	CI
Nihon Chouzai Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2023	22-04-28	CI
Nihon Chouzai to Adopt an Executive Officer System	22-02-22	MT
Nihon Chouzai Co.,Ltd. Provides Dividend Guidance for the Year Ending March 31, 2022	22-01-31	CI
Nihon Chouzai Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022	22-01-31	CI
Nihon Chouzai Co.,Ltd. Announces for the Second Quarter Ended September 30, 2021, Payable on December 6, 2021; Provides Dividend Guidance for the Year Ending March 31, 2022	21-10-29	CI
Nihon Chouzai Co.,Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2022	21-10-29	CI
Nihon Chouzai Co.,Ltd. agreed to acquire remaining 44.71% stake in Choseido Pharmaceutical Co., Ltd. for ¥5.8 billion.	21-10-20	CI
Nihon Chouzai Co.,Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2021	21-07-30	CI
Nihon Chouzai Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2022	21-07-30	CI
Nihon Chouzai Co., Ltd. Provides Dividend Guidance for the Second Quarter and Fiscal Year Ending March 31, 2022	21-07-30	CI
Nihon Chouzai Co.,Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Fiscal Year Ended March 31, 2021	21-04-30	CI

Chart NIHON CHOUZAI Co.,Ltd.

Duration

Period

More charts

Company Profile

NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.

Sector

Drug Retailers

Calendar

2024-04-29 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for NIHON CHOUZAI Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1,507 JPY

Average target price

1,503 JPY

Spread / Average Target

-0.24%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

	1st Jan change	Capi.
NIHON CHOUZAI CO.,LTD.	+7.72%	299M
RAIA DROGASIL S.A.	-13.44%	8.11B
AIN HOLDINGS INC.	+31.63%	1.34B
QOL HOLDINGS CO., LTD.	+2.78%	419M
SALUS, LJUBLJANA, D. D.	+13.33%	231M
GREEN CROSS HEALTH LIMITED	-6.42%	88.36M
MEDICAL IKKOU GROUP CO.,LTD.	+18.81%	59.48M

Retail - Drugs without Grocery